Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02947269Phase 3Completed
Phase 3, randomised, double-blind trial of prucalopride in postoperative ileus (POI) (2 arms), sponsored by The University of Auckland. Primary endpoint: Time until recovery of gastrointestinal function. Started Oct 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02947269.